INTRODUCTION
Acinetobacter baumannii is emerging as a nosocomial pathogen, particularly in intensive care units, including burn care units (Bayram et al., 2013; Guzek et al., 2013; Ohashi et al., 2013) . Hospitalized patients at a greater risk of Acinetobacter infections are those particularly ill on a ventilator, those with a prolonged hospital stay, those who have open wounds and those with invasive devices, such as urinary catheters (Wendt et al., 1997; Wisplinghoff et al., 2000; Ho et al., 2010; Howard et al., 2012; Zheng et al., 2013) .
A stepwise evolution in the acquisition of multidrug resistance in clinical isolates of Pseudomonas aeruginosa and A. baumannii has been reported (Higgins et al., 2010; Asai et al., 2011) . Elucidation of the mechanism(s) underlying the drug resistance is important to prevent such resistance.
We identified a series of clinical isolates of drug-resistant (DR) A. baumannii with a diverse pattern of drug resistance from eight patients in the emergency intensive care unit (EICU) of Tokai University Hospital from March 2010 to November 2011. In order to elucidate the diversity on drug resistance in the same sequence type, we studied the molecular characteristics of the clinical isolates and the relationship with the resistance pattern.
METHODS
Patients and clinical specimens. The patients studied were admitted to the EICU (57 beds, including three beds in the severe burn care unit) of Tokai University Hospital (total 804 beds), because of serious burns, traffic injuries or cerebral haemorrhage. During this period, all patients, except two with cerebral haemorrhage, were treated by the systemic administration of antibiotics, including b-lactams, fluoroquinolones, aminoglycosides and glycopeptides, for infections of wounds and/or the respiratory tract.
Routine microbial examinations were performed on a weekly basis on clinical specimens from the patients' sputum, urine (via catheter), venous blood, wounds, etc.
Bacteriological surveillance of environmental surfaces was performed for the medical equipment shared by the patients in order to seek a possible reservoir of the pathogen, such as an air-fluidized bed. A drug-sensitive strain of A. baumannii (A. baumannii Tokai strain 9; resistance pattern SSS, see below) was used as a control. The epidemiological investigation was performed to elucidate the possible transmission route using information on the clinical care of the patients and detection of A. baumannii. The study was approved by the Review Board of Tokai University (13R-036).
Growth conditions and antibiotic susceptibility testing. Bacteria were cultured at 37 uC in Luria-Bertani broth (Kyokuto Pharmaceutical Industrial). The criteria for multidrug-resistant (MDR) A. baumannii was resistance to imipenem (IPM; MIC .16 mg ml 21 ), amikacin (AMK; MIC .32 mg ml 21 ) and ciprofloxacin (CPFX; MIC .4 mg ml 21 ), and DR A. baumannii was defined as being resistant to one or two of the drugs according to the Japanese National Guideline Concerning the Prevention of Infections and Medical Care for Patients with Infections.
Biochemical identification and susceptibility testing of the isolates was performed to obtain MIC values using a microdilution method (CLSI, 2009 ) and the MicroScan WalkAway-96 SI system (Siemens Japan). The antibiotics used in this study were obtained as follows: AMK and IPM were from Banyu Pharmaceutical, aztreonam (AZT) was from Eizai, ceftazidime (CAZ) was from Glaxo SmithKline, cefepime (CFPM) was from Bristol-Myers Squibb, CPFX was from Bayer HealthCare, cefozopran (CZOP) was from Takeda Pharmaceutical, doripenem (DRPM) was from Shionogi, fosfomycin (FOM) was from Meiji Seika, gentamicin (GM) was from Schering-Plough, levofloxacin (LVFX) was from Daiichi-Sankyo Pharmaceutical, meropenem (MEPM) was from Daiichi-Sumitomo Pharmaceutical, minocycline (MINO) was from Wyeth & Takeda Pharmaceutical, piperacillin (PIPC) was from Taisho Toyama Pharmaceutical and tobramycin (TOB) was from Towa Pharmaceutical.
Molecular typing. DNA templates were extracted using a ZR-Duet DNA/RNA MiniPrep kit (Zymo Research). Multilocus sequence typing (MLST) was performed as described previously (Bartual et al., 2005; Fu et al., 2010) . MLST sequences were uploaded into the A. baumannii MLST Sequence Type Database (http://pubmlst.org/ abaumannii/) to determine the alleles and sequence types. A. baumannii isolates were screened for gene homology by a repetitive-element-based PCR (rep-PCR) DiversiLab Microbial Typing System (Sysmex bioMérieux), which amplified the regions between the non-coding repetitive sequences in bacterial genomes, as described previously (Carretto et al., 2008; Higgins et al., 2012) . The annealing temperature of the PCR amplification used in this study was 55 uC for gltA, gyrB, recA and cpn60, and 50 uC for gdhB, gpi and rpoD. The amplification products were purified with a DNA purification kit (Qiagen). The DNA sequencing was performed using an ABI3500xL Genetic Analyzer (Applied Biosystems).
Evaluation of the mechanisms of resistance
Screening for metallo-b-lactamase (MBL). A. baumannii isolates were screened for the production of MBL by a double-disc synergy test with discs containing sodium mercaptoacetic acid as described previously (Arakawa et al., 2000) .
PCR assay for b-lactamase and armA. The following resistance genes were examined by PCR: bla IMP-1 , bla VIM , bla OXA-23-like , bla OXA-24-like , bla OXA-51-like , bla OXA-58-like and ISAba1, as described previously (Turton et al., 2006; Woodford et al., 2006) . The armA gene, which encodes 16S rRNA methylases and confers high resistance to aminoglycosides, was screened by PCR using primers that were described previously (Yamane et al., 2005) .
Sequencing of OXA-type b-lactamase, and gyrA and parC.
Sequencing of OXA-type b-lactamase was performed as described previously (Endo et al., 2012) . The quinolone resistance-determining regions of gyrA and parC were amplified and analysed as described previously (Liu et al., 2012) . DNA sequencing of the amplified DNA products was performed using an ABI3500xL Genetic Analyzer (Applied Biosystems).
Quantitative real-time (qRT)-PCR). RNA templates were extracted by a ZR-Duet DNA/RNA MiniPrep kit (Zymo Research). The expression levels of three different genes encoding resistancenodulation-division (RND) family pumps (adeB, adeG and adeJ) and two different genes encoding outer-membrane porins (oprD and carO) were analysed by qRT-PCR using a StepOnePlus RealTime PCR System (Applied Biosystems) (Peleg et al., 2008; Fernando & Kumar, 2012; Zander et al., 2013) . The primers used for the analysis are listed in Table 1 . The housekeeping gene 16S rRNA was used as a control (Coyne et al., 2010; Srinivasan et al., 2011; Hou et al., 2012) . Reactions (20 ml) were set up using 400 nM primers and 2 ml cDNA template (diluted 1 : 10) with SYBR Premix Ex Taq II (Tli RNaseH Plus) and ROX plus (Takara Bio). The data analysis was carried out using StepOne software. The expression of each target gene was normalized based on the level of the 16S rRNA mRNA gene and was expressed as a relative rate compared with that in the susceptible isolate of each pair (the expression of A. baumannii Tokai strain 9 was taken as 1.0). Experiments were conducted at least three times independently and all reactions were carried out in triplicate.
RESULTS

Bacterial strains and antibiotic susceptibility
The characteristics of the A. baumannii Tokai strains are shown in Table 2 . In March 2010, a DR A. baumannii Tokai strain 1 was detected initially from the wound of a patient with a severe burn injury. After 1.5 years, during a period of 3 months from August to November 2011, another seven clinical isolates of DR A. baumannii strains from patients (A. baumannii Tokai strains 2-8) were obtained. The DR A. baumannii Tokai strains were classified into three types according to their susceptibility to three drugs (IPM, AMK and CPFX) as RRR, SRR or SSR (R, resistant; S, susceptible; Tables 2 and 3). They were obtained from sputum, wounds and bile drains.
As the interval between the first patient and the others was long (.18 months), the environment of the ward was suspected to be a possible reservoir of the pathogen. Based on the results of the bacteriological surveillance of environmental surfaces, A. baumannii Tokai strain 10 was isolated from the cracks of a rubber frame and a lump of beads in an air-fluidized bed that was used by five patients during their hospitalization (A. baumannii Tokai strains 1, 2 and 4-6).
Molecular typing
The molecular genotyping of isolates by a MLST analysis revealed a sequence type of ST208 for A. baumannii Tokai strains 1-8 and 10 (ST profile, gltA-gyrB-gdhB-recAcpn60-gpi-rpoD: 1-3-3-2-2-97-3) and another type for A. baumannii Tokai strain 9 (ST profile, gltA-gyrBgdhB-recA-cpn60-gpi-rpoD: 15-48-58-42-36-54-41). The molecular genotyping of isolates by rep-PCR showed the same pattern (.97 % similarity) as one type for eight of the isolates (A. baumannii Tokai strains 1-7 and 10) (Fig.  1) , and the other isolates (A. baumannii Tokai strains 8 and 9) had different patterns (85 and ,70 % similarity, respectively).
Expression of resistance-related genes
The MBL assay of the clinically isolated A. baumannii Tokai strains revealed no apparent MBL production and all isolates showed expression of OXA-51-like carrying OXA-66 b-lactamase (Table 4 ). The expression of IMP-1, VIM, OXA-23-like, OXA-24-like and OXA-58-like was negative. Expression of ISAba1 and armA was found in A. baumannii Tokai strains 1-7 and 10. The DNA sequencing of gyrA and parC revealed that Ser83 (TCA) was changed to TTA (Leu) and that Ser80 (TCG) was changed to TTT (Phe) or TTG (Leu) in A. baumannii Tokai strains 1-8 and 10.
Our analysis of genes encoding RND pumps included an analysis of the expression of three previously characterized genes, adeB, adeG and adeJ, which encode the RND pump in the adeABC, adeFGH and adeIJK operons, respectively. The result of A. baumannii Tokai strains 1, 2, 8 and 9 as representative strains from each group with the same susceptibility pattern is shown in Table 5 . Overexpression of adeB and adeJ was seen in A. baumannii Tokai strain 2. The expression of oprD was decreased in A. baumannii Tokai strains 2 and 8. Underexpression of carO was seen in isolates with A. baumannii Tokai strains 1, 2 and 8.
DISCUSSION
We investigated a series of clinical isolates of DR A. baumannii ST208 in the EICU of Tokai University Hospital. In order to elucidate the diversity of the drug resistance patterns in the same sequence type in these isolates, we studied the molecular characteristics of these isolates and their relationship with the resistance pattern.
A. baumannii Tokai strains 1-7 and 10 were positive for OXA-51-like and OXA-66 b-lactamase and ISAba1. A. baumannii strains with resistance to AMK (A. baumannii Tokai strains 1-7 and 10) were positive for armA. These results are consistent with the idea that ISAba1 regulates the expression of OXA-51-like carrying OXA-66 blactamase and that armA is related to aminoglycoside resistance. The five isolates (A. baumannii Tokai strains 1, 2 and 4-6) could have been derived from the same source and/or transmitted horizontally, because the same airfluidized bed had been used by those patients. Among them, A. baumannii Tokai strains 2, 4 and 6 showed multidrug resistance (RRR). These patients were treated with carbapenem (MEPM or DRPM) prior to sampling for at least 1 week, which may have played a role in the overexpression of adeB and adeJ in A. baumannii Tokai strain 2. A. baumannii Tokai strain 10 was detected from the cracks of the rubber frame and a lump of beads in an air-fluidized bed, even though the bed had been cleaned and disinfected every time after use. Although a few nosocomial outbreaks of A. baumannii ST2 have been reported (Suzuki et al., 2013; Yamada & Suwabe, 2013) , an outbreak of A. baumannii ST208 has not been reported previously in Japan.
As the pattern of the rep-PCR and sequence type of MLST in the eight isolates was the same as that in the initial case, it was suggested that the strain survived for 1.5 years in the environmental reservoir. As infection control procedures, careful attention to environmental cleaning and disinfection in order to reduce the risk of transmission is suggested. A. baumannii Tokai strain 8 (SSR) was also ST208, but had a different pattern as shown by rep-PCR. During the transmission from the same original organism, the presence of a transposon or the insertion of a different plasmid might have led to the different pattern. During the period of an outbreak, A. baumannii with different drug susceptibility patterns appeared depending on the various resistance mechanisms.
Nine isolates (A. baumannii Tokai strains 1-8 and 10) had resistance to CPFX, which can be explained by the mutations of gyrA and parC. Another major factor contributing to the resistance of this organism was the overexpression of the RND pumps (Fernando & Kumar, 2012; Amin et al., 2013; Zander et al., 2013) . Our analysis of genes encoding RND pumps included the expression of three previously characterized genes, adeB, adeG and adeJ, which encode the RND pumps in the adeABC, adeFGH and adeIJK operons, respectively. Efflux pumps such as AdeABC have been reported to be involved in multidrug resistance (Vila et al., 2007; Hou et al., 2012) . In our study, A. baumannii Tokai strain 2 (RRR) showed overexpression of adeB and adeJ. A. baumannii Tokai strain 8 showed better sensitivity to some b-lactams (CAZ, CFPM and CZOP) than that of A. baumannii Tokai strain 9 (SSS). This phenomenon might be associated with underexpression of adeB. Two pumps, such as adeB and adeJ, have been related to the acquisition of multidrug resistance. As for porins, the overexpression of genes encoding RND pumps and the downregulation of genes encoding porins is known to be common in clinical isolates of Acinetobacter spp. (Fernando et al., 2013) . Our findings also suggest that the underexpression of carO in combination with or without oprD does not result in resistance to carbapenem in A. baumannii Tokai strains 1 and 8 (SRR and SSR). This observation is consistent with previous findings showing that a decrease in porins among Acinetobacter strains is not associated with resistance to carbapenems in the presence of b-lactamases (Rumbo et al., 2013; Singh et al., 2013) .
In conclusion, we demonstrated that drug resistance is associated with the expression of ISAba1 and armA, and mutations in gyrA and parC, and that the overexpression of adeB and adeJ plays a role in the multidrug resistance of A. baumannii Tokai strain ST208. 
